Followers | 15 |
Posts | 1835 |
Boards Moderated | 0 |
Alias Born | 04/16/2024 |
Thursday, June 06, 2024 7:41:26 PM
australian KOL on IOBT
many things pointing at it becoming the SOC one day...
Recent IOBT News
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2024 09:16:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2024 01:50:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/23/2024 11:56:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/23/2024 11:53:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2024 01:10:30 PM
- IO Biotech secures up to €57.5 million in debt financing from the European Investment Bank • GlobeNewswire Inc. • 12/20/2024 01:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/16/2024 11:06:59 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 09:30:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 12:11:53 PM
- IO Biotech Reports Third Quarter 2024 Financial Results and Provides Business Highlights • GlobeNewswire Inc. • 11/12/2024 12:05:00 PM
- IO Biotech Announces Participation in Upcoming Investor Conferences • GlobeNewswire Inc. • 11/11/2024 09:05:00 PM
- IO Biotech Reports its Off-the-Shelf Therapeutic Cancer Vaccine, IO102-IO103, in Combination with KEYTRUDA® Demonstrates Promising Activity and Durability in First-line Treatment of Patients with Metastatic Lung Cancer in Phase 2 IOB-022 Study • GlobeNewswire Inc. • 11/07/2024 03:00:00 PM
- IO Biotech Announces Two Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting • GlobeNewswire Inc. • 10/04/2024 01:00:00 PM
- IO Biotech Announces Positive Results from Phase 2 Trial of IO102-IO103 in the First-line Treatment of Advanced Head and Neck Cancer • GlobeNewswire Inc. • 09/14/2024 06:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2024 08:10:54 PM
- IO Biotech Updates on Pivotal Phase 3 Trial of IO102-IO103 in Combination with KEYTRUDA® (pembrolizumab) as a First-Line Treatment for Patients with Advanced Melanoma • GlobeNewswire Inc. • 08/30/2024 08:05:00 PM
- IO Biotech Announces Participation in Upcoming Investor Conferences • GlobeNewswire Inc. • 08/26/2024 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:06:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 11:05:59 AM
- IO Biotech Reports Second Quarter 2024 Financial Results and Provides Business Highlights • GlobeNewswire Inc. • 08/13/2024 11:05:00 AM
- IO Biotech Announces New Head and Neck Cohort Data Accepted for Presentation at ESMO Congress 2024 • GlobeNewswire Inc. • 07/25/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2024 08:44:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:18:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:14:19 PM
- IO Biotech to Present at Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/23/2024 12:30:00 PM
The Crypto Company Highlights Blockchain Training Alliance's Successes and Momentum for 2025 • CRCW • Dec 26, 2024 8:58 AM
Hertz Energy Provides Antimony and Critical Minerals Projects Update and Announces Financing • HZLIF • Dec 20, 2024 9:00 AM
North Bay Resources Announces Arrival of 42 Tons Gold Ore at Bishop Gold Mill, California • NBRI • Dec 20, 2024 9:00 AM
Consumer Automotive Finance Subsidiary Drago Knives Narrows Down Potential Partner to Manufacture Patented Throwing Knives • CAFI • Dec 20, 2024 9:00 AM
$ASNS - Is this the Next Big Cybersecurity Stock? How Actelis Networks is Revolutionizing Critical Infrastructure Protection • ASNS • Dec 20, 2024 8:50 AM
UAV Corp's (UMAV), Skyborne Technology to Build "SKY" Hangar at Its Costin Airport Scheduled for Groundbreaking Ceremony Winter 2025 • UMAV • Dec 20, 2024 8:30 AM